Klaria Pharma Holding Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Klaria Pharma Holding
Access all reports
Klaria Pharma Holding AB is a Swedish biotechnology and medical research company focused on developing and commercializing therapeutic drugs. The company's core technology involves a patented drug delivery platform using an alginate-based polymer film that facilitates rapid and reliable transmucosal absorption. This innovative method allows the medication to be distributed directly into the bloodstream via a mucoadhesive film, offering benefits such as shorter time to effect, increased control, and simple handling. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
KLAR
Country
🇸🇪 Sweden